Lilly reports third-quarter 2014 results
Eli Lilly reported 2014 third quarter worldwide total revenue was $4.876 billion, a decrease of 16 percent versus the same 2013 period. In the 2014 third quarter, net income and EPS decreased 58 percent to $500.6 million and $0.47, respectively, compared with the same 2013 quarter. October 23, 2014